GAM
Griffin Asset Management Portfolio holdings
AUM
$847M
This Quarter Return
+2.45%
1 Year Return
+15.48%
3 Year Return
+82.66%
5 Year Return
+141.95%
10 Year Return
–
AUM
$276M
AUM Growth
–
Cap. Flow
+$276M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
33%
Holding
118
New
118
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IBM
IBM
|
$15.7M |
| 2 |
Exxon Mobil
XOM
|
$13.2M |
| 3 |
GE Aerospace
GE
|
$10.3M |
| 4 |
Johnson & Johnson
JNJ
|
$8.82M |
| 5 |
Chevron
CVX
|
$7.69M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 19.22% |
| 2 | Consumer Staples | 15.58% |
| 3 | Industrials | 13.72% |
| 4 | Technology | 12.63% |
| 5 | Financials | 12.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
IBM
IBM
$227B
| $15.7M | 5.67% | +82,016 | New | +$15.7M |
|
|
2
Exxon Mobil
XOM
$487B
| $13.2M | 4.78% | +146,200 | New | +$13.2M |
|
|
3
GE Aerospace
GE
$292B
| $10.3M | 3.71% | +442,414 | New | +$10.3M |
|
|
4
Johnson & Johnson
JNJ
$427B
| $8.82M | 3.19% | +102,677 | New | +$8.82M |
|
|
5
Chevron
CVX
$324B
| $7.69M | 2.78% | +64,945 | New | +$7.69M |
|
6
Wells Fargo
WFC
$263B
| $7.32M | 2.65% | +177,304 | New | +$7.32M |
|
7
American Express
AXP
$231B
| $7.15M | 2.59% | +95,596 | New | +$7.15M |
|
8
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.08M | 2.56% | +42 | New | +$7.08M |
|
9
Microsoft
MSFT
$3.77T
| $7.02M | 2.54% | +203,114 | New | +$7.02M |
|
10
Merck
MRK
$210B
| $7.01M | 2.54% | +150,880 | New | +$7.01M |
|
11
Procter & Gamble
PG
$368B
| $6.9M | 2.5% | +89,632 | New | +$6.9M |
|
12
Coca-Cola
KO
$297B
| $6.51M | 2.36% | +162,380 | New | +$6.51M |
|
13
Honeywell
HON
$139B
| $6.47M | 2.34% | +81,554 | New | +$6.47M |
|
14
Target
TGT
$43.6B
| $6.41M | 2.32% | +93,068 | New | +$6.41M |
|
15
PepsiCo
PEP
$204B
| $6.07M | 2.2% | +74,234 | New | +$6.07M |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $5.61M | 2.03% | +126,989 | New | +$5.61M |
|
17
Home Depot
HD
$405B
| $5.3M | 1.92% | +68,380 | New | +$5.3M |
|
18
Intel
INTC
$107B
| $5.2M | 1.88% | +214,682 | New | +$5.2M |
|
19
AbbVie
ABBV
$372B
| $5.09M | 1.84% | +123,007 | New | +$5.09M |
|
20
Baxter International
BAX
$12.7B
| $5.02M | 1.82% | +72,468 | New | +$5.02M |
|
21
Novartis
NVS
$245B
| $4.85M | 1.76% | +68,653 | New | +$4.85M |
|
|
DD
22
DELISTED
Du Pont De Nemours E I
DD
| $4.64M | 1.68% | +88,396 | New | +$4.64M |
|
23
Bristol-Myers Squibb
BMY
$96B
| $4.43M | 1.6% | +99,123 | New | +$4.43M |
|
24
3M
MMM
$82.8B
| $4.21M | 1.52% | +38,536 | New | +$4.21M |
|
25
Emerson Electric
EMR
$74.3B
| $4.18M | 1.51% | +76,557 | New | +$4.18M |
|